Skip to main content
. 2019 Jan 23;18:2325958218821963. doi: 10.1177/2325958218821963

Table 1.

Baseline Demographic and Clinical Characteristics of Study Participants Stratified by Tenofovir Exposure.a

Characteristics Strata All Patients, N = 4897 TDF-Exposed (a), n = 2104 (43%) TDF-Unexposed (b), n = 2793 (57%) P Value, (a) versus (b)
Sex Female 2969 (60.63) 1188 (40.01) 1781 (59.99) <.001b
Male 1928 (39.37) 916 (47.51) 1012 (52.49)
Age range ≤50 3715 (75.91) 1642 (44.2) 2073 (55.8) .002b
>50 1179 (24.09) 460 (39.02) 719 (60.98)
Age, years Median (IQR) 42 (36-49) 41 (35-48) 42 (36-50) <.001c
Weight, kg Median (IQR) 53 (61-70) 60 (52-70) 60 (53-69) .334c
Hepatitis B or C No 2163 (72.61) 675 (31.21) 1488 (68.79) <.001b
Yes 816 (27.39) 358 (43.87) 458 (56.13)
WHO clinical stage 1 or 2 2168 (68.41) 638 (29.43) 1530 (70.57) <.001b
3 or 4 1001 (31.59) 432 (43.16) 569 (56.84)
Viral load, copies/mL ≤10 000 2804 (67.02) 1092 (38.94) 1712 (61.06) .120b
>10 000 1380 (32.98) 572 (41.45) 808 (58.55)
Log10 3.5 (4.6-5.2) 3.64 (4.59-5.28) 3.45 (4.52-5.18) .002c
CD4 cells/mm3 ≤100 1316 (27.04) 586 (44.53) 730 (55.47) .154b
>100 3550 (72.96) 1500 (42.25) 2050 (57.75)
Median (IQR) 94 (182-298) 91 (188-319) 95 (180-284.25) .731c
Creatinine (mmol/L) Median (IQR) 64 (80-103) 74.05 (59-92.91) 83 (66-106) <.001c
CrCl, (mL/min) Median (IQR) 62 (82-104) 97.73 (76.2-126.3) 87.26 (66.4-112.2) <.001c
eGFR (mL/min/1.73 m2) Median (IQR) 70 (92-118) 102.48 (80.2-130.7) 88.07 (66.4-112.4) <.001c

Abbreviations: CrCl, creatinine clearance; eGFR, estimated glomerular filtration rate; IQR, interquartile range; TDF, tenofovir disoproxil fumarate; WHO, World Health Organization.

a The number in parenthesis is percentages except indicated otherwise.

b The comparison was by χ2 for categorical variables.

c Mann-Whitney U test was used for comparison of median values.